1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow MEDI4736 in combination with AZD5069: new trials by email Literature Review of MEDI4736 in combination with AZD5069 trials Research Report on MEDI4736 in combination with AZD5069
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma MEDI4736 in combination with nab-paclitaxel and gemcitabine, MEDI4736 in combination with AZD5069 - Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Completed | AstraZeneca | 23 | 2016-03-25 | 2019-08-14 |
Anophthalmia with pulmonary hypoplasia (1)
AstraZeneca (1)
United Kingdom (1) · United States (1)
Jeff Evans, M.D (1)